image
image
user-login
Patent search/

ROTARY STAGE ASEPTIC FILLING SYSTEMS FOR PHARMACEUTICAL CONTAINERS

search

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

ROTARY STAGE ASEPTIC FILLING SYSTEMS FOR PHARMACEUTICAL CONTAINERS

ORDINARY APPLICATION

Published

date

Filed on 26 November 2024

Abstract

ABSTRACT Rotary Stage Aseptic Filling Systems for Pharmaceutical Containers The present disclosure introduces a rotary stage aseptic filling system for pharmaceutical containers 100 designed to ensure efficient filling of various container types. The system incorporates rotary filling station 102 for continuous container movement and advanced filling nozzles 108 for accurate dispensing. The aseptic barrier system 106 maintains controlled environment while integrated sterilization system 110 ensures continuous aseptic conditions. The container handling mechanism 104 securely transfers containers, and automated changeover mechanism 118 facilitates rapid reconfiguration for diverse container sizes. Real-time monitoring is achieved through environmental monitoring sensors 114, with data analytics and reporting module 116 capturing insights for regulatory compliance. Predictive maintenance system 124 minimizes downtime by forecasting equipment failures, and training and simulation module 140 enhances operator proficiency. Additional components are safety interlock mechanisms 120 and integrated waste management system 126. Reference Fig 1

Patent Information

Application ID202441092084
Invention FieldMECHANICAL ENGINEERING
Date of Application26/11/2024
Publication Number48/2024

Inventors

NameAddressCountryNationality
K RaghavendraVenkatapur (V), Ghatkesar (M), Medchal Malkajgiri DT. Hyderabad, Telangana, IndiaIndiaIndia

Applicants

NameAddressCountryNationality
Anurag UniversityVenkatapur (V), Ghatkesar (M), Medchal Malkajgiri DT. Hyderabad, Telangana, IndiaIndiaIndia

Specification

Description:Rotary Stage Aseptic Filling Systems for Pharmaceutical Containers
TECHNICAL FIELD
[0001] The present innovation relates to rotary stage aseptic filling systems for automated, sterile filling of pharmaceutical containers, enhancing precision, sterility, and production efficiency.

BACKGROUND

[0002] The pharmaceutical industry demands stringent sterility and precision in manufacturing processes, particularly in aseptic filling for injectable formulations. Traditional aseptic filling methods, often manual or semi-automated, present significant challenges, including sterility risks, low efficiency, and limited scalability. These methods are labor-intensive, prone to human error, and susceptible to contamination, resulting in variations in fill volumes, higher production costs, and increased risk to patient safety. As demand for sterile pharmaceuticals and biologics grows, manufacturers have sought advanced technologies to meet production requirements while maintaining strict quality standards.

[0003] Rotary stage filling systems have emerged as a solution, offering continuous container movement and reduced contamination risk. However, existing systems face several limitations. Many lack flexibility to accommodate diverse container sizes and shapes, resulting in prolonged changeover times and reduced productivity. Design inefficiencies, such as suboptimal filling nozzles and inadequate environmental controls, may compromise sterility and filling accuracy. Additionally, existing systems often fail to provide comprehensive data analytics, real-time monitoring, and ease of compliance with regulatory requirements.

[0004] The present invention addresses these drawbacks by introducing a highly efficient rotary stage aseptic filling system with advanced design features. Key innovations include modular rotary mechanisms for scalability, adaptive filling nozzles for precision across various formulations, and integrated sterilization methods such as UV light or vaporized hydrogen peroxide for consistent sterility. A robust aseptic barrier with real-time environmental monitoring ensures a controlled environment, while automated changeover mechanisms minimize downtime. The system's data analytics and reporting modules enhance process optimization and regulatory compliance.

[0005] The novelty of this invention lies in its modular, flexible design and comprehensive features, enabling manufacturers to overcome the challenges of traditional systems. By ensuring sterility, accuracy, and efficiency, the invention significantly enhances pharmaceutical manufacturing processes, supporting the production of high-quality, safe medications.

OBJECTS OF THE INVENTION

[0006] The primary object of the invention is to provide a rotary stage aseptic filling system that ensures precise, sterile filling of pharmaceutical containers while maintaining strict compliance with regulatory standards.

[0007] Another object of the invention is to enhance production efficiency by employing a rotary mechanism that allows simultaneous filling of multiple containers, reducing production time and increasing throughput.

[0008] Another object of the invention is to improve sterility assurance through integrated aseptic barriers, advanced sterilization methods, and real-time environmental monitoring systems.

[0009] Another object of the invention is to offer flexibility and adaptability by incorporating a modular design that accommodates various container sizes and shapes, minimizing downtime during changeovers.

[00010] Another object of the invention is to achieve greater accuracy in fill volumes through advanced filling nozzle calibration and advanced control systems, reducing waste and ensuring consistency.

[00011] Another object of the invention is to enhance operator usability and safety by integrating an intuitive human-machine interface (HMI) and ergonomic design features.

[00012] Another object of the invention is to enable seamless integration with upstream and downstream pharmaceutical manufacturing systems, such as washing, sterilization, and packaging lines, for a fully automated production workflow.

[00013] Another object of the invention is to facilitate regulatory compliance and traceability through automated data logging, reporting, and batch documentation features.

[00014] Another object of the invention is to promote sustainability in pharmaceutical manufacturing by utilizing energy-efficient components and eco-friendly materials in the system design.

[00015] Another object of the invention is to support predictive maintenance and reduce operational disruptions by employing advanced machine learning algorithms to analyze performance data and anticipate equipment failures.





SUMMARY OF THE INVENTION

[00016] In accordance with the different aspects of the present invention, rotary stage aseptic filling systems for pharmaceutical containers is presented. It is designed to efficiently and precisely fill pharmaceutical containers such as vials and syringes while maintaining strict sterility. It features a modular rotary mechanism, advanced filling nozzles, integrated sterilization systems, and robust aseptic barriers to ensure contamination-free operations. The system enhances production efficiency, supports diverse container types, and incorporates real-time monitoring and automated reporting for regulatory compliance. Its energy-efficient and sustainable design promotes environmentally friendly manufacturing. The invention addresses limitations of traditional systems, ensuring superior accuracy, flexibility, and sterility in pharmaceutical production.

[00017] Additional aspects, advantages, features and objects of the present disclosure would be made apparent from the drawings and the detailed description of the illustrative embodiments constructed in conjunction with the appended claims that follow.

[00018] It will be appreciated that features of the present disclosure are susceptible to being combined in various combinations without departing from the scope of the present disclosure as defined by the appended claims.

BRIEF DESCRIPTION OF DRAWINGS
[00019] The summary above, as well as the following detailed description of illustrative embodiments, is better understood when read in conjunction with the appended drawings. For the purpose of illustrating the present disclosure, exemplary constructions of the disclosure are shown in the drawings. However, the present disclosure is not limited to specific methods and instrumentalities disclosed herein. Moreover, those in the art will understand that the drawings are not to scale. Wherever possible, like elements have been indicated by identical numbers.

[00020] Embodiments of the present disclosure will now be described, by way of example only, with reference to the following diagrams wherein:

[00021] FIG. 1 is component wise drawing for rotary stage aseptic filling systems for pharmaceutical containers.

[00022] FIG 2 is working methodology of rotary stage aseptic filling systems for pharmaceutical containers.

DETAILED DESCRIPTION

[00023] The following detailed description illustrates embodiments of the present disclosure and ways in which they can be implemented. Although some modes of carrying out the present disclosure have been disclosed, those skilled in the art would recognise that other embodiments for carrying out or practising the present disclosure are also possible.

[00024] The description set forth below in connection with the appended drawings is intended as a description of certain embodiments of rotary stage aseptic filling systems for pharmaceutical containers and is not intended to represent the only forms that may be developed or utilised. The description sets forth the various structures and/or functions in connection with the illustrated embodiments; however, it is to be understood that the disclosed embodiments are merely exemplary of the disclosure that may be embodied in various and alternative forms. The figures are not necessarily to scale; some features may be exaggerated or minimised to show details of particular components. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a representative basis for teaching one skilled in the art to variously employ the present invention.

[00025] While the disclosure is susceptible to various modifications and alternative forms, specific embodiment thereof has been shown by way of example in the drawings and will be described in detail below. It should be understood, however, that it is not intended to limit the disclosure to the particular forms disclosed, but on the contrary, the disclosure is to cover all modifications, equivalents, and alternatives falling within the scope of the disclosure.

[00026] The terms "comprises", "comprising", "include(s)", or any other variations thereof, are intended to cover a non-exclusive inclusion, such that a setup, or system that comprises a list of components or steps does not include only those components or steps but may include other components or steps not expressly listed or inherent to such setup or system. In other words, one or more elements in a system or apparatus preceded by "comprises... a" does not, without more constraints, preclude the existence of other elements or additional elements in the system or apparatus.

[00027] In the following detailed description of the embodiments of the disclosure, reference is made to the accompanying drawings and which are shown by way of illustration-specific embodiments in which the disclosure may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the disclosure, and it is to be understood that other embodiments may be utilized and that changes may be made without departing from the scope of the present disclosure. The following description is, therefore, not to be taken in a limiting sense.

[00028] The present disclosure will be described herein below with reference to the accompanying drawings. In the following description, well-known functions or constructions are not described in detail since they would obscure the description with unnecessary detail.

[00029] Referring to Fig. 1, rotary stage aseptic filling systems for pharmaceutical containers 100 is disclosed in accordance with one embodiment of the present invention. It comprises of rotary filling station 102, container handling mechanism 104, aseptic barrier system 106, advanced filling nozzles 108, integrated sterilization system 110, control system 112, environmental monitoring sensors 114, data analytics and reporting module 116, automated changeover mechanism 118, safety interlock mechanisms 120, energy-efficient components 122, predictive maintenance system 124, integrated waste management system 126, traceability and compliance features 128, collaborative robotics integration 130, advanced leak detection system 132, real-time alerts and notifications 134, human-machine interface 136, customizable filling algorithms 138, training and simulation module 140.

[00030] Referring to Fig. 1, the present disclosure provides details of rotary stage aseptic filling systems for pharmaceutical containers 100. It is an advanced system designed to enable sterile, efficient, and precise filling of pharmaceutical containers such as vials and syringes. The system ensures sterility, accuracy, and adaptability in production processes through key components such as rotary filling station 102, container handling mechanism 104, and aseptic barrier system 106, which maintain a contamination-free environment. The system incorporates advanced filling nozzles 108 and integrated sterilization system 110 for accurate and sterile filling. Real-time monitoring is achieved via environmental monitoring sensors 114 and data analytics and reporting module 116, while automated changeover mechanism 118 enhances operational efficiency. Additional features include predictive maintenance system 124, traceability and compliance features 128, and customizable filling algorithms 138 to optimize performance and ensure regulatory compliance.

[00031] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with rotary filling station 102, which is the central component enabling simultaneous filling of multiple containers in a circular configuration. It ensures continuous container movement through the filling process, minimizing exposure to non-sterile environments. The rotary filling station 102 integrates seamlessly with advanced filling nozzles 108 to deliver precise fill volumes and reduce waste. Its modular design allows scalability, directly supporting the claim of a dynamic and efficient system. The rotary filling station 102 works closely with the container handling mechanism 104 to ensure a smooth, sterile transfer of containers into the system.

[00032] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with container handling mechanism 104, which is responsible for securely transferring containers into and out of the filling system. It employs robotic arms or conveyors with adjustable grips to accommodate containers of various sizes and shapes. The container handling mechanism 104 ensures contamination-free transfer by integrating with aseptic barrier system 106, maintaining sterility throughout the process. Its flexible design enables seamless integration with rotary filling station 102, reducing downtime during changeovers, thereby fulfilling claims related to adaptability and operational efficiency.

[00033] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with aseptic barrier system 106, which creates a controlled sterile environment around the filling area. It utilizes HEPA filters and positive pressure airflow to prevent airborne contaminants from entering the system. The aseptic barrier system 106 works in conjunction with environmental monitoring sensors 114 to continuously track conditions such as particulate matter and pressure. This integration ensures sterility, directly supporting claims regarding contamination reduction and sterility assurance. It also enhances the effectiveness of integrated sterilization system 110, maintaining aseptic conditions throughout the filling process.

[00034] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with advanced filling nozzles 108, which are designed to deliver precise fill volumes with minimal waste. These nozzles use dynamic calibration to adapt to the viscosity of different formulations, ensuring consistent performance across product types. The advanced filling nozzles 108 interact with rotary filling station 102 to ensure smooth and accurate dispensing during the filling process. Their anti-drip and splash-free design supports claims of accuracy and sterility, reducing cross-contamination risks. They also integrate with data analytics and reporting module 116 to monitor and adjust performance parameters in real time.

[00035] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with integrated sterilization system 110, which ensures that all contact surfaces and equipment remain aseptic during production. It employs methods such as UV light and vaporized hydrogen peroxide to sterilize components continuously. The integrated sterilization system 110 works closely with aseptic barrier system 106 to maintain a controlled environment. This component directly supports claims related to enhanced sterility assurance and compliance with pharmaceutical regulations. Its continuous operation reduces downtime for manual sterilization, improving overall system efficiency.

[00036] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with control system 112, which manages all operational parameters, including filling speed, volume accuracy, and environmental conditions. It utilizes programmable logic controllers (PLCs) and human-machine interfaces (HMIs) to enable real-time monitoring and control of the system. The control system 112 interacts with environmental monitoring sensors 114 to dynamically adjust airflow, pressure, and other variables, ensuring sterility. It also integrates with data analytics and reporting module 116 to provide actionable insights and alerts, fulfilling claims related to automation, compliance, and operational efficiency.

[00037] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with environmental monitoring sensors 114, which continuously track parameters such as temperature, humidity, and particulate matter within the aseptic environment. These sensors work in tandem with aseptic barrier system 106 to ensure that environmental conditions remain within predefined sterile limits. The environmental monitoring sensors 114 integrate with control system 112 to trigger automatic adjustments when deviations are detected. This component directly supports claims of real-time monitoring and enhanced sterility assurance, minimizing contamination risks during production.

[00038] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with data analytics and reporting module 116, which collects and analyzes operational data to optimize the filling process. This module generates detailed reports for regulatory compliance and quality assurance. The data analytics and reporting module 116 works closely with control system 112 to monitor performance metrics and detect anomalies in real time. It also interacts with predictive maintenance system 124 to forecast potential equipment failures, supporting claims of efficiency, compliance, and operational reliability.

[00039] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with automated changeover mechanism 118, which allows for rapid reconfiguration of filling parameters, such as nozzle sizes and fill volumes, to accommodate different container specifications. The mechanism integrates seamlessly with rotary filling station 102 and container handling mechanism 104, ensuring minimal downtime during production transitions. This component directly addresses claims of adaptability and efficiency, enabling manufacturers to switch between product lines with ease while maintaining sterile conditions.

[00040] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with safety interlock mechanisms 120, which prevent unauthorized access to the sterile filling area during operation. These interlocks ensure that the aseptic barrier system 106 remains uncompromised, protecting both product quality and operator safety. The safety interlock mechanisms 120 work in conjunction with control system 112 to trigger alerts and halt operations if a breach occurs. This component supports claims related to enhanced safety and sterility assurance, ensuring compliance with pharmaceutical manufacturing standards.

[00041] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with energy-efficient components 122, which include low-energy motors and smart airflow management systems designed to minimize energy consumption during operation. These components interact with control system 112 to optimize energy use without compromising performance. The energy-efficient components 122 directly support claims of sustainability, reducing the environmental impact of pharmaceutical manufacturing processes while maintaining high efficiency.

[00042] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with predictive maintenance system 124, which employs machine learning algorithms to analyze operational data and predict potential equipment failures. This system works closely with data analytics and reporting module 116 to identify trends and anomalies, enabling timely maintenance actions. The predictive maintenance system 124 helps reduce downtime and extends equipment lifespan, fulfilling claims of operational reliability and efficiency.

[00043] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with integrated waste management system 126, which automatically collects and segregates waste materials generated during the filling process. This system works in conjunction with container handling mechanism 104 to ensure that waste is managed without disrupting production. The integrated waste management system 126 supports claims of sustainability and cleanliness, promoting a sterile and eco-friendly manufacturing environment.
[00044] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with traceability and compliance features 128, which include barcode scanning, batch tracking, and automated documentation generation. These features integrate with data analytics and reporting module 116 to ensure that every step of the filling process is recorded and traceable. The traceability and compliance features 128 support claims of regulatory adherence and product accountability, enhancing quality assurance processes.

[00045] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with collaborative robotics integration 130, which includes cobots designed to assist in tasks such as loading and unloading containers. These cobots work seamlessly with container handling mechanism 104 to improve productivity while maintaining sterility. Collaborative robotics integration 130 supports claims of enhanced efficiency and operator safety, reducing manual intervention and workload.

[00046] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with advanced leak detection system 132, which identifies leaks during the filling process to ensure container integrity. This system integrates with control system 112 to trigger alerts when leaks are detected, allowing for immediate corrective action. The advanced leak detection system 132 supports claims of quality assurance and sterility by ensuring that only sealed and defect-free containers proceed to downstream processes.

[00047] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with real-time alerts and notifications 134, which provide operators with visual and auditory cues for deviations in parameters such as fill volumes, environmental conditions, and equipment malfunctions. These alerts work in conjunction with control system 112 to facilitate prompt responses to operational issues. The real-time alerts and notifications 134 directly support claims of enhanced usability, safety, and operational efficiency.
[00048] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with human-machine interface 136, which offers an intuitive platform for operators to monitor and control the filling process. The interface displays real-time visualizations of system performance, environmental conditions, and diagnostics. The human-machine interface 136 integrates with data analytics and reporting module 116 to provide actionable insights, supporting claims of usability and efficiency.

[00049] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with customizable filling algorithms 138, which adapt to the viscosity of different pharmaceutical formulations and container specifications. These algorithms work closely with advanced filling nozzles 108 and control system 112 to ensure precise and consistent fill volumes. The customizable filling algorithms 138 support claims of adaptability, accuracy, and waste reduction, ensuring optimal performance across diverse product lines.

[00050] Referring to Fig. 1, rotary stage aseptic filling system for pharmaceutical containers 100 is provided with training and simulation module 140, which offers virtual training scenarios for operators to familiarize themselves with the system. This module integrates with human-machine interface 136 to simulate real-world operational conditions, reducing errors and enhancing operator proficiency. The training and simulation module 140 supports claims of usability and safety, ensuring efficient and error-free system operation.

[00051] Referring to Fig 2, there is illustrated method 200 for rotary stage aseptic filling systems for pharmaceutical containers 100. The method comprises:
At step 202, method 200 includes containers being fed into the rotary filling station 102 using the container handling mechanism 104, which securely transfers the containers while maintaining sterility;
At step 204, method 200 includes containers entering the aseptic barrier system 106, where a controlled environment with HEPA filters and positive pressure airflow prevents contamination;
At step 206, method 200 includes containers being sterilized using the integrated sterilization system 110, which employs methods such as ultraviolet light or vaporized hydrogen peroxide to ensure all surfaces are aseptic;
At step 208, method 200 includes the rotary filling station 102 aligning containers with the advanced filling nozzles 108 for precise dispensing of pharmaceutical formulations, with real-time calibration to ensure accuracy;
At step 210, method 200 includes environmental monitoring sensors 114 continuously tracking parameters like temperature and particulate matter to maintain sterile conditions, with adjustments made automatically by the control system 112;
At step 212, method 200 includes filled containers being capped or processed further, with the automated changeover mechanism 118 ensuring rapid reconfiguration for different container sizes or products;
At step 214, method 200 includes data being captured by the data analytics and reporting module 116, providing insights and documentation for regulatory compliance and quality assurance;
At step 216, method 200 includes predictive maintenance system 124 analyzing operational data to identify potential equipment issues, ensuring uninterrupted operation;
At step 218, method 200 includes waste generated during the process being managed by the integrated waste management system 126, which segregates and collects materials to maintain cleanliness and sustainability;
At step 220, method 200 includes safety interlock mechanisms 120 preventing unauthorized access to the sterile filling area, ensuring sterility and operator safety;
At step 222, method 200 includes collaborative robotics integration 130 assisting in loading and unloading containers, enhancing productivity while maintaining sterility;
At step 224, method 200 includes advanced leak detection system 132 inspecting containers for leaks, ensuring they are properly sealed and defect-free;
At step 226, method 200 includes real-time alerts and notifications 134 providing operators with visual and auditory cues for operational deviations;
At step 228, method 200 includes human-machine interface 136 enabling operators to monitor and adjust system performance, ensuring usability and safety;
At step 230, method 200 includes customizable filling algorithms 138 adapting parameters based on product viscosity and container specifications for optimal performance;
At step 232, method 200 includes training and simulation module 140 offering virtual training scenarios to enhance operator proficiency before actual system operation.
[00052] The rotary stage aseptic filling system for pharmaceutical containers 100 is designed to address the stringent requirements of sterile pharmaceutical manufacturing, offering a versatile solution for filling vials, syringes, and other containers with precision and efficiency. Applications include the production of injectable drugs, biologics, and vaccines where maintaining sterility is paramount. The system enhances production efficiency with the rotary filling station 102 and automated changeover mechanism 118, ensuring high throughput and adaptability to diverse container types. The aseptic barrier system 106 and integrated sterilization system 110 maintain strict sterility, reducing contamination risks. Real-time monitoring through environmental monitoring sensors 114 and data analytics and reporting module 116 ensures compliance with regulatory standards. Predictive maintenance system 124 minimizes downtime, while the integrated waste management system 126 promotes cleanliness and sustainability. Overall, the invention improves product quality, operational efficiency, and safety in pharmaceutical production.

[00053] In the description of the present invention, it is also to be noted that, unless otherwise explicitly specified or limited, the terms "fixed" "attached" "disposed," "mounted," and "connected" are to be construed broadly, and may for example be fixedly connected, detachably connected, or integrally connected, either mechanically or electrically. They may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meaning of the above terms in the present invention can be understood in specific cases to those skilled in the art.

[00054] Modifications to embodiments of the present disclosure described in the foregoing are possible without departing from the scope of the present disclosure as defined by the accompanying claims. Expressions such as "including", "comprising", "incorporating", "have", "is" used to describe and claim the present disclosure are intended to be construed in a non- exclusive manner, namely allowing for items, components or elements not explicitly described also to be present. Reference to the singular is also to be construed to relate to the plural where appropriate.

[00055] Although embodiments have been described with reference to a number of illustrative embodiments thereof, it should be understood that numerous other modifications and embodiments can be devised by those skilled in the art that will fall within the spirit and scope of the principles of this disclosure. More particularly, various variations and modifications are possible in the component parts and/or arrangements of the subject combination arrangement within the scope of the present disclosure, the drawings and the appended claims. In addition to variations and modifications in the component parts and/or arrangements, alternative uses will also be apparent to those skilled in the art.
, Claims:WE CLAIM:
1. A rotary stage aseptic filling systems for pharmaceutical containers 100 comprising of
rotary filling station 102 to enable continuous movement and alignment of containers for efficient filling;
container handling mechanism 104 to securely transfer containers into and out of the system while maintaining sterility;
aseptic barrier system 106 to provide a controlled sterile environment with HEPA filtration and positive airflow;
advanced filling nozzles 108 to ensure precise dispensing of pharmaceutical formulations with real-time calibration;
integrated sterilization system 110 to maintain aseptic conditions using ultraviolet light or vaporized hydrogen peroxide;
control system 112 to automate adjustments and monitor operational parameters in real time;
environmental monitoring sensors 114 to continuously track conditions such as temperature, humidity, and particulate matter;
data analytics and reporting module 116 to capture, analyze, and document operational data for quality assurance;
automated changeover mechanism 118 to enable rapid reconfiguration for different container sizes or products;
safety interlock mechanisms 120 to prevent unauthorized access and ensure sterility during operation;
energy-efficient components 122 to reduce energy consumption while maintaining system performance;
predictive maintenance system 124 to forecast and prevent equipment failures through machine learning;
integrated waste management system 126 to segregate and collect waste materials for cleanliness and sustainability;
traceability and compliance features 128 to ensure batch tracking and regulatory adherence through barcode scanning and documentation;
collaborative robotics integration 130 to assist in container handling tasks, enhancing productivity and safety;
advanced leak detection system 132 to identify and address leaks, ensuring container integrity;
real-time alerts and notifications 134 to inform operators of deviations and operational issues;
human-machine interface 136 to provide an intuitive platform for monitoring and controlling system performance;
customizable filling algorithms 138 to adapt parameters for optimal performance based on product and container specifications; and
training and simulation module 140 to offer virtual training scenarios for operator proficiency and error reduction.
2. The rotary stage aseptic filling system for pharmaceutical containers 100 as claimed in claim 1, wherein rotary filling station 102 is configured to enable continuous movement of containers in a circular arrangement, reducing non-sterile exposure and ensuring high-throughput precision filling for various container types.

3. The rotary stage aseptic filling system for pharmaceutical containers 100 as claimed in claim 1, wherein advanced filling nozzles 108 are configured with dynamic calibration to adapt to varying viscosities of pharmaceutical formulations, ensuring consistent fill accuracy and minimizing liquid waste.

4. The rotary stage aseptic filling system for pharmaceutical containers 100 as claimed in claim 1, wherein aseptic barrier system 106 is configured with HEPA filtration and positive pressure airflow to create a controlled sterile environment, effectively preventing airborne contamination throughout the filling process.

5. The rotary stage aseptic filling system for pharmaceutical containers 100 as claimed in claim 1, wherein integrated sterilization system 110 is configured to continuously sterilize contact surfaces and components using ultraviolet light or vaporized hydrogen peroxide, ensuring uninterrupted aseptic conditions during operation.

6. The rotary stage aseptic filling system for pharmaceutical containers 100 as claimed in claim 1, wherein container handling mechanism 104 is configured with adjustable grips and robotic integration to securely transfer containers of various sizes and shapes while maintaining sterility and operational efficiency.

7. The rotary stage aseptic filling system for pharmaceutical containers 100 as claimed in claim 1, wherein data analytics and reporting module 116 is configured to capture real-time process data, generate actionable insights, and automate compliance reporting to meet regulatory standards and optimize system performance.

8. The rotary stage aseptic filling system for pharmaceutical containers 100 as claimed in claim 1, wherein predictive maintenance system 124 is configured to analyze operational data using machine learning algorithms, predicting equipment failures to minimize downtime and enhance system reliability.

9. The rotary stage aseptic filling system for pharmaceutical containers 100 as claimed in claim 1, wherein automated changeover mechanism 118 is configured to enable rapid reconfiguration of filling parameters and container specifications, reducing downtime and enhancing system adaptability for diverse production requirements.

10. The rotary stage aseptic filling systems for pharmaceutical containers 100 as claimed in claim 1, wherein method comprises of
containers being fed into the rotary filling station 102 using the container handling mechanism 104, which securely transfers the containers while maintaining sterility;
containers entering the aseptic barrier system 106, where a controlled environment with hepa filters and positive pressure airflow prevents contamination;
containers being sterilized using the integrated sterilization system 110, which employs methods such as ultraviolet light or vaporized hydrogen peroxide to ensure all surfaces are aseptic;
the rotary filling station 102 aligning containers with the advanced filling nozzles 108 for precise dispensing of pharmaceutical formulations, with real-time calibration to ensure accuracy;
environmental monitoring sensors 114 continuously tracking parameters like temperature and particulate matter to maintain sterile conditions, with adjustments made automatically by the control system 112;
filled containers being capped or processed further, with the automated changeover mechanism 118 ensuring rapid reconfiguration for different container sizes or products;
data being captured by the data analytics and reporting module 116, providing insights and documentation for regulatory compliance and quality assurance;
predictive maintenance system 124 analyzing operational data to identify potential equipment issues, ensuring uninterrupted operation;
waste generated during the process being managed by the integrated waste management system 126, which segregates and collects materials to maintain cleanliness and sustainability;
safety interlock mechanisms 120 preventing unauthorized access to the sterile filling area, ensuring sterility and operator safety;
collaborative robotics integration 130 assisting in loading and unloading containers, enhancing productivity while maintaining sterility;
advanced leak detection system 132 inspecting containers for leaks, ensuring they are properly sealed and defect-free;
real-time alerts and notifications 134 providing operators with visual and auditory cues for operational deviations;
human-machine interface 136 enabling operators to monitor and adjust system performance, ensuring usability and safety;
customizable filling algorithms 138 adapting parameters based on product viscosity and container specifications for optimal performance;
training and simulation module 140 offering virtual training scenarios to enhance operator proficiency before actual system operation.

Documents

NameDate
202441092084-COMPLETE SPECIFICATION [26-11-2024(online)].pdf26/11/2024
202441092084-DECLARATION OF INVENTORSHIP (FORM 5) [26-11-2024(online)].pdf26/11/2024
202441092084-DRAWINGS [26-11-2024(online)].pdf26/11/2024
202441092084-EDUCATIONAL INSTITUTION(S) [26-11-2024(online)].pdf26/11/2024
202441092084-EVIDENCE FOR REGISTRATION UNDER SSI [26-11-2024(online)].pdf26/11/2024
202441092084-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [26-11-2024(online)].pdf26/11/2024
202441092084-FIGURE OF ABSTRACT [26-11-2024(online)].pdf26/11/2024
202441092084-FORM 1 [26-11-2024(online)].pdf26/11/2024
202441092084-FORM FOR SMALL ENTITY(FORM-28) [26-11-2024(online)].pdf26/11/2024
202441092084-FORM-9 [26-11-2024(online)].pdf26/11/2024
202441092084-POWER OF AUTHORITY [26-11-2024(online)].pdf26/11/2024
202441092084-REQUEST FOR EARLY PUBLICATION(FORM-9) [26-11-2024(online)].pdf26/11/2024

footer-service

By continuing past this page, you agree to our Terms of Service,Cookie PolicyPrivacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.